Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Non-FDG PET/CT imaging of inflammatory arthritis.
Journal: Skeletal radiology
Published: January 07, 2025
Alpha-emitter therapy for pediatric relapsed metastatic pancreatic neuroendocrine tumor.
Journal: Pediatric blood & cancer
Published: December 19, 2023
Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 27, 2023
Targeted α-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 15, 2021
Comparison of MRI, [18F]FDG PET/CT, and 99mTc-UBI 29-41 scintigraphy for postoperative spondylodiscitis-a prospective multicenter study.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 12, 2020
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
Journal: Current opinion in endocrinology, diabetes, and obesity
Published: April 07, 2020
64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 09, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026